AirStrip
Technologies has received CE Mark certification to market its mobile patient
monitoring applications in the European Community as well as other
international territories outside Europe.
This is a
significant milestone that indicates our FDA-cleared solutions also meet the
quality and safety standards required by the international healthcare
marketplace.
In obtaining
the CE Mark, AirStrip Technologies demonstrates that it conforms to
international quality benchmarks for medical devices, including ISO standards.
We have seen
an incredible level of interest in bringing our applications to Europe and
other territories, and we can now aggressively move forward with our expansion
plans,” said AirStrip Technologies
CEO Alan Portela.
Applications
currently available include AirStrip OB, AirStrip CARDIOLOGY and AirStrip
PATIENT MONITORING, which are now used by thousands of clinicians at hundreds
of US hospitals. The applications give clinicians anytime, anywhere access to
vital live and historical patient data including waveforms, ECGs and other
information, right on their smartphone or tablet.
AirStrip
recently announced a partnership with Qualcomm Life Inc., a subsidiary of
Qualcomm, to develop and execute a home health monitoring initiative that
integrates AirStrip solutions into the Qualcomm 2netTM Platform. The
focus will be on helping curb hospital readmission rates for congestive heart
failure patients.
International
commercialization is the exciting next step in expanding the availability of
AirStrip’s native applications, which enable more timely and accurate diagnosis
and treatment and are already in strong demand globally,” said
AirStrip Technologies Executive Vice President and Chief Strategy
Officer Bruce Brandes.
By
Telecomlead.com Team
[email protected]
